Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.745 USD | -3.80% | -5.38% | +33.92% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Financials (USD)
Sales 2024 * | 139M | Sales 2025 * | 164M | Capitalization | 577M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -11M | EV / Sales 2024 * | 4.15 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.52 x |
P/E ratio 2024 * |
-28.6
x | P/E ratio 2025 * |
-48.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Avid Bioservices, Inc.
1 day | -2.92% | ||
1 week | -4.24% | ||
Current month | +15.47% | ||
1 month | +31.89% | ||
3 months | +13.83% | ||
6 months | +60.48% | ||
Current year | +35.54% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 1,487 M€ | +9.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 8.71 | -4.18% | 199 259 |
24-05-22 | 9.09 | +0.11% | 534,781 |
24-05-21 | 9.08 | -2.16% | 656,802 |
24-05-20 | 9.28 | +1.75% | 987,627 |
24-05-17 | 9.12 | -0.87% | 2,295,448 |
Delayed Quote Nasdaq, May 23, 2024 at 12:08 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.54% | 577M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.08% | 32.79B | |
+64.13% | 26.23B | |
-21.85% | 14.52B | |
-7.63% | 13.09B | |
-42.60% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- CDMO Stock